January 12, 2021
Private longevity research companies deserve investor attention as the longevity side of the life science market grows.
December 23, 2019
INN takes a look at the pharma trends of 2019 that have shaken up the space this year and created...
November 12, 2019
The Phase 1/2 clinical trial of AVB-500 is being done in combination with durvalumab in patients with ovarian cancer.
October 8, 2019
With Q4 in full swing, it's time to reflect on the top-performing NASDAQ pharma stocks year-to-date.
October 2, 2019
The company's inhaler therapy, Trelegy Ellipta, has already been approved in the US for chronic obstructive pulmonary disease.
August 29, 2019
The victory comes almost exactly a year after AstraZeneca's lupus treatment didn't meet its primary endpoints in a different trial.
July 10, 2019
With Q2 2019 officially over, the Investing News Network shares a pharma market update on the biggest news and trends...